51
|
Lv L, Wang X. MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer. Oncol Res 2017; 26:775-783. [PMID: 29241478 PMCID: PMC7844729 DOI: 10.3727/096504017x15132494420120] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
Cervical cancer is the third most commonly diagnosed malignancy and the fourth leading cause of cancer-related deaths in women worldwide. MicroRNA-296 (miR-296) is aberrantly expressed in a variety of human cancer types. However, the expression levels, biological roles, and underlying molecular mechanisms of miR-296 in cervical cancer remain unclear. This study aimed to detect miR-296 expression in cervical cancer and evaluate its roles and underlying mechanisms in cervical cancer. This study demonstrated that miR-296 was significantly downregulated in cervical cancer tissues and cell lines. Restoring the expression of miR-296 inhibited the proliferation and invasion of cervical cancer cells. Moreover, miR-296 directly targeted the 3'-untranslated regions of specificity protein 1 (SP1) and decreased its endogenous expression at both the mRNA and protein levels. Similar to induced miR-296 expression, SP1 knockdown suppressed the proliferation and invasion of cervical cancer cells. Besides, resumption expression of SP1 rescued the tumor-suppressing roles of miR-296 in cervical cancer. These results indicated that miR-296 may act as a tumor suppressor in cervical cancer by directly targeting SP1. Therefore, SP1 may be developed as a therapeutic target for the treatment of patients with this malignancy.
Collapse
Affiliation(s)
- Lili Lv
- Department of Oncology and Hematology, The Second Hospital of Jilin University, Changchun, Jilin, P.R. China
| | - Xiaodong Wang
- Department of Digestive Endoscopy, The Second Hospital of Jilin University, Changchun, Jilin, P.R. China
| |
Collapse
|
52
|
Wang J, Guo L, Shen D, Xu X, Wang J, Han S, He W. The Role of c-SKI in Regulation of TGFβ-Induced Human Cardiac Fibroblast Proliferation and ECM Protein Expression. J Cell Biochem 2017; 118:1911-1920. [PMID: 28214335 DOI: 10.1002/jcb.25935] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2017] [Accepted: 02/16/2017] [Indexed: 12/14/2022]
Abstract
Cardiac fibrosis is characterized by over-deposition of extracellular matrix (ECM) proteins and over-proliferation of cardiac fibroblast, and contributes to both systolic and diastolic dysfunction in many cardiac pathophysiologic conditions. Transforming growth factor β 1 (TGFβ1) is as an essential inducing factor of cardiac fibrosis. C-Ski protein has been identified as an inhibitory regulator of TGFβ signaling. In the present study, we revealed the repressive effect of c-Ski on TGFβ1-induced human cardiac fibroblast (HCFB) proliferation and ECM protein increase (Collagen I and α-SMA). Moreover, miR-155 and miR-17 could inhibit SKI mRNA expression by direct binding to the 3'UTR of SKI, so as to reduce c-Ski protein level. Either miR-155 inhibition or miR-17 inhibition could reverse TGFβ1-induced HCFB proliferation and ECM protein increase. Taken together, we provided a potential therapy to treat cardiac fibrosis by inhibiting miR-155/miR-17 so as to restore the repressive effect of c-Ski on TGFβ1 signaling. J. Cell. Biochem. 118: 1911-1920, 2017. © 2017 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Juan Wang
- Department of Cardiology, the Fifth Affiliated Hospital of Xin Jiang Medical University, Urumchi, 830001,, Xin Jiang, China
| | - Liping Guo
- Department of Cardiology, the Fifth Affiliated Hospital of Xin Jiang Medical University, Urumchi, 830001,, Xin Jiang, China
| | - Difei Shen
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China
| | - Xiao Xu
- Department of Oncology, the First Affiliated Hospital of Xin Jiang Medical University, Urumchi, 830001,, Xin Jiang, China
| | - Jiaping Wang
- Department of Pharmacy, the Fifth Affiliated Hospital of Xin Jiang Medical University, Urumchi, 830001,, Xin Jiang, China
| | - Suxia Han
- Department of Cardiology, the Fifth Affiliated Hospital of Xin Jiang Medical University, Urumchi, 830001,, Xin Jiang, China
| | - Wen He
- Department of Pharmacy, the Fifth Affiliated Hospital of Xin Jiang Medical University, Urumchi, 830001,, Xin Jiang, China
| |
Collapse
|